These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3160957)

  • 21. Assessment of neurotoxicity of clioquinol (Enterovioform) by visual evoked potentials. A preliminary communication.
    Bhasin DK; Raina R; Mehta SK; Arora MM
    Indian J Gastroenterol; 1985 Jul; 4(3):165-6. PubMed ID: 3160659
    [No Abstract]   [Full Text] [Related]  

  • 22. Peripheral neuropathy in rats fed with clioquinol.
    Jones EL; Searle CE; Smith WT
    J Pathol; 1972 Jul; 107(3):P8-9. PubMed ID: 4263803
    [No Abstract]   [Full Text] [Related]  

  • 23. [SMON outside Japan--a neurologic evaluation].
    Silfverskiöld B
    Lakartidningen; 1980 May; 77(19):1821-2. PubMed ID: 7392712
    [No Abstract]   [Full Text] [Related]  

  • 24. [A iatrogenic disease... subacute myelo-optico-neuropathy].
    Degos CF; Thomas-Lamotte PJ
    Rev Prat; 1977 Jun; 27(35):2277-85. PubMed ID: 143057
    [No Abstract]   [Full Text] [Related]  

  • 25. [Subacute myelo-optic-neuropathy during treatment with chloro-iodo-hydroxyquinoleine (author's transl)].
    Charasz N; Vacherot B; Dougados M; Bousser MG; Belaiche J; Cattan D
    Gastroenterol Clin Biol; 1979 Apr; 3(4):371-4. PubMed ID: 159200
    [No Abstract]   [Full Text] [Related]  

  • 26. Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols.
    Sturtevant FM
    Pediatrics; 1980 Mar; 65(3):610-3. PubMed ID: 6444713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there SMON in India?
    Wadia NH
    Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127
    [No Abstract]   [Full Text] [Related]  

  • 28. [SMON (subacute myelo-optico-neuropathy)].
    Kusui K
    Naika; 1971 Mar; 27(3):485-7. PubMed ID: 4926303
    [No Abstract]   [Full Text] [Related]  

  • 29. Clioquinol's return: cautions from Japan.
    Tabira T
    Science; 2001 Jun; 292(5525):2251-2. PubMed ID: 11424945
    [No Abstract]   [Full Text] [Related]  

  • 30. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
    Bron HL; Korten JJ; Pinckers AJ; Majoor CL
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
    [No Abstract]   [Full Text] [Related]  

  • 31. Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey.
    Nakae K; Yamamoto S; Shigematsu I; Kono R
    Lancet; 1973 Jan; 1(7796):171-3. PubMed ID: 4118793
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neurological complications in the course of treatment of acrodermatitis enteropathica with oxyquinoline derivatives].
    Papuziński M; Wilmowska-Pietruszyńska A
    Pediatr Pol; 1974 Nov; 49(11):1393-7. PubMed ID: 4278959
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurotoxicity of oxyquinolines.
    Hansson O; Herxheimer A
    Lancet; 1980 Jun; 1(8180):1253-4. PubMed ID: 6104069
    [No Abstract]   [Full Text] [Related]  

  • 34. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
    Selby G
    Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
    [No Abstract]   [Full Text] [Related]  

  • 35. Clioquinol: time to act.
    de Pinto O; Burley D
    Lancet; 1977 Jun; 1(8024):1256. PubMed ID: 68347
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serious sensory-motor neuropathy. A case of renal failure following clioquinol absorption].
    Gendre JP; Barbanel C; Degos JD; Le Quintrec Y
    Nouv Presse Med; 1974 Nov; 3(37):2395-8. PubMed ID: 4282135
    [No Abstract]   [Full Text] [Related]  

  • 37. [Subacute myelopathy during a course of treatment with clioquinol in a patient colectomized for Crohn's disease].
    Fabiani F; Pompili A; Scarinci A; Sinibaldi L
    Riv Neurobiol; 1978; 24(1-2):121-37. PubMed ID: 161413
    [No Abstract]   [Full Text] [Related]  

  • 38. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
    Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
    Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
    [No Abstract]   [Full Text] [Related]  

  • 39. Outline of the joint SMON investigation by the clinical section.
    Kusui K
    Jpn J Med Sci Biol; 1975; 28 Suppl():57-62. PubMed ID: 136541
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship between neurological symptoms and concentrations of clioquinol in serum and nervous systems of beagle dogs.
    Hayakawa K; Imanari T; Tamura Z; Kuroda S; Ikeda H; Tateishi J
    Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):2013-8. PubMed ID: 144569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.